DEXCOM INC's ticker is and the CUSIP is 252131AK3. A total of 67 filers reported holding DEXCOM INC in Q3 2022. The put-call ratio across all filers is 4.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,800 | -9.0% | 4,800,000 | 0.0% | 0.01% | -14.3% |
Q1 2024 | $5,273 | +5.3% | 4,800,000 | 0.0% | 0.01% | 0.0% |
Q4 2023 | $5,009 | +11.1% | 4,800,000 | 0.0% | 0.01% | 0.0% |
Q3 2023 | $4,508 | -11.8% | 4,800,000 | 0.0% | 0.01% | -12.5% |
Q2 2023 | $5,111 | +0.3% | 4,800,000 | 0.0% | 0.02% | -11.1% |
Q1 2023 | $5,096 | -2.2% | 4,800,000 | 0.0% | 0.02% | -5.3% |
Q4 2022 | $5,212 | -99.9% | 4,800,000 | 0.0% | 0.02% | +5.6% |
Q3 2022 | $4,460,000 | -93.3% | 4,800,000 | -12.3% | 0.02% | -92.9% |
Q2 2022 | $66,421,000 | +1105.7% | 5,475,000 | +14.1% | 0.25% | +1231.6% |
Q1 2022 | $5,509,000 | -93.5% | 4,800,000 | -12.3% | 0.02% | -93.3% |
Q4 2021 | $85,129,000 | -6.4% | 5,475,000 | -42.2% | 0.28% | -16.0% |
Q3 2021 | $90,907,000 | +14.0% | 9,475,000 | 0.0% | 0.34% | +19.0% |
Q2 2021 | $79,733,000 | – | 9,475,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PIER 88 INVESTMENT PARTNERS LLC | 17,495,000 | $16,120,000 | 3.83% |
SSI INVESTMENT MANAGEMENT LLC | 34,177,000 | $31,482,000 | 2.11% |
Liberty Mutual Group Asset Management Inc. | 4,075,000 | $3,754,000 | 1.13% |
ADVENT CAPITAL MANAGEMENT /DE/ | 64,568,000 | $59,806,000 | 1.08% |
MACKAY SHIELDS LLC | 43,555,000 | $40,304,000 | 1.02% |
SHENKMAN CAPITAL MANAGEMENT INC | 18,523,000 | $17,071,000 | 0.96% |
ZAZOVE ASSOCIATES LLC | 9,022,000 | $8,360,000 | 0.76% |
Calamos Advisors LLC | 66,187,000 | $61,330,000 | 0.28% |
RWC Asset Management LLP | 6,000,000 | $5,566,000 | 0.19% |
PALISADE CAPITAL MANAGEMENT, LP | 6,219,000 | $5,766,000 | 0.16% |